Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
Still, the press release does not make it clear to me that the disease has been moved to NINDS.
Yeay!!!!!"While not made explicit in this press release, a source at the NIH confirmed that this means that ME/CFS will no longer be housed under the Office of Women’s Health and has been formally moved to NINDS."
I emailed and asked if we were being moved into NINDS. Below is the reply:
Management of CFSAC, the advisory committee, remains with OWH. The announcement today is about NIH’s work on ME/CFS and doesn’t apply to other efforts around the Department. For example, CDC continues to have research and educational projects and funding for these efforts.
________________________________________________________
The CFSAC Support Team
Email: cfsac@hhs.gov
Website: http://www.hhs.gov/advcomcfs/index.html
Sign up for the CFSAC listserv to receive the latest updates about CFSAC:
http://www.hhs.gov/advcomcfs/cfsac_email_list
I emailed and asked if we were being moved into NINDS. Below is the reply:
Management of CFSAC, the advisory committee, remains with OWH. The announcement today is about NIH’s work on ME/CFS and doesn’t apply to other efforts around the Department. For example, CDC continues to have research and educational projects and funding for these efforts.
"While not made explicit in this press release, a source at the NIH confirmed that this means that ME/CFS will no longer be housed under the Office of Women’s Health and has been formally moved to NINDS."
What has CFSAC ever done, especially lately, besides obfuscation, lip service, and political gaming? Why not dissolve CFSAC, and dissociate from OWH completely?
CDC should now follow the example of NIH and move ME to NINDS. C'mon already.
I emailed and asked if we were being moved into NINDS. Below is the reply:
Management of CFSAC, the advisory committee, remains with OWH. The announcement today is about NIH’s work on ME/CFS and doesn’t apply to other efforts around the Department. For example, CDC continues to have research and educational projects and funding for these efforts.
I have not quite caffeinated yet, @Denise, so was just trying to say this disease is past due to be removed from OWH.I am not sure I understand what you are saying @leela.
CDC and NIH are separate branches of HHS, so I don't think CDC could move ME to NINDS
though they could move it out of National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Division of High-Consequence Pathogens and Pathology (DHCPP).
The Atlantic said:The National Institutes of Health announced on Thursday that it will strengthen its efforts to find the roots of a mysterious disorder known as Chronic Fatigue Syndrome, or Myalgic Encephalomyelitis. Researchers from a number of the agency’s institutes will design a clinical study involving individuals who developed crippling fatigue and other symptoms after an acute infection. The agency may also increase the funding dedicated to the disorder from its current level of about $5 million annually, less than the amount devoted to hay fever.
“The effort aims to take advantage of the NIH Clinical Center, the largest research hospital in the world, to try to carry out every kind of imaginable analysis of the immune system, neurological system … metabolism … all of the things you'd want to know to try to get a handle on what is driving this very mysterious, puzzling disorder,” the NIH director Francis Collins said in an interview. “Given the seriousness the of condition, I don't think we have focused enough of our attention on this.”
The Atlantic said:The new CFS initiative will have upgraded prestige and visibility, Collins said, falling under the authority of Walter J. Koroshetz, the director of the National Institute of Neurological Disorders and Stroke, along with Vicky Holets Whittemore, the NIH representative to the U.S. Department of Health and Human Services’ Chronic Fatigue Syndrome Advisory Committee.
Dr. House is in the house.Encouraging bit from Koroshetz biography:
In other words, we have a person with a special interest in biomarkers leading the research effort. Let's hope that he is passionate and highly motivated!